University General Hospital Of Thessaloniki Ahepa

The medical center is at the forefront of neurological research, focusing on innovative treatments for acute ischemic stroke. Through rigorous clinical trials, the center is exploring the efficacy of novel therapeutic agents aimed at improving patient outcomes.

• Acute Ischemic Stroke

By advancing the understanding of stroke mechanisms, the center contributes significantly to the development of effective interventions that can be applied in clinical settings worldwide.

Specializing in glaucoma and ocular hypertension, the center is dedicated to preserving vision through cutting-edge research. The focus is on assessing the efficacy of various pharmacological treatments to prevent visual field deterioration.

• Glaucoma
• Ocular Hypertension

These efforts are crucial in developing therapies that maintain visual health and improve the quality of life for patients with progressive eye conditions.

The center is a leader in the study of pulmonary arterial hypertension (PAH), investigating the impact of new treatments on pulmonary vascular resistance and exercise capacity. This research is vital for enhancing therapeutic strategies for PAH patients.

• Pulmonary Arterial Hypertension

Through these studies, the center aims to improve patient outcomes and provide evidence-based recommendations for PAH management.

Focusing on severe infections, the center is pioneering approaches to optimize antibiotic use and improve diagnostic accuracy. This research is essential for combating antibiotic resistance and enhancing patient care.

• Severe Infections

By integrating molecular diagnostics, the center is setting new standards in the treatment of complex infections.

The center is advancing the treatment of Ewing Sarcoma and acute myeloid leukemia through international collaborative trials. These studies aim to optimize therapeutic regimens and improve survival rates for young patients.

• Ewing Sarcoma
• Acute Myeloid Leukemia

By focusing on innovative treatment strategies, the center is making significant contributions to pediatric oncology.

Research in classical Hodgkin lymphoma is a key focus, with trials aimed at evaluating the efficacy of novel immunotherapies. This work is crucial for developing targeted treatments that improve patient outcomes.

• Classical Hodgkin Lymphoma

The center's efforts in this area are paving the way for more effective and personalized treatment options for young patients.